The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 1000-1012 , December 2009

Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study

  • Shu-fei Lin

      Affiliations

    • Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland at Baltimore, Baltimore, MD 21201, USA
    • ,
  • Hua Wei

      Affiliations

    • Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland at Baltimore, Baltimore, MD 21201, USA
    • ,
  • Dennis Maeder

      Affiliations

    • University of Maryland Biotechnology Institute, Baltimore, MD 21201, USA
    • ,
  • Renty B. Franklin

      Affiliations

    • Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland at Baltimore, Baltimore, MD 21201, USA
    • Greenebaum Cancer Center, University of Maryland at Baltimore, Baltimore, MD 21201, USA
    • ,
  • Pei Feng

      Affiliations

    • Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland at Baltimore, Baltimore, MD 21201, USA
    • Greenebaum Cancer Center, University of Maryland at Baltimore, Baltimore, MD 21201, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 706 7340; fax: +1 410 706 0865.

Received 20 May 2008 ,Revised 3 September 2008 ,Accepted 9 September 2008.

References 

  1. Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother. 2003;57:399–411
  2. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C. Zinc: a multipurpose trace element. Arch Toxicol. 2006;80:1–9
  3. Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, Kaczmarek LK, et al. Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci U S A. 2003;100:6157–6162
  4. Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate. 1998;35:285–296
  5. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999;40:200–207
  6. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC. Effect of zinc on prostatic tumorigenicity in nude mice. Ann N Y Acad Sci. 2003;1010:316–320
  7. Iguchi K, Hamatake M, Ishida R, Usami Y, Adachi T, Yamamoto H, et al. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem. 1998;253:766–770
  8. Feng P, Liang JY, Li TL, Guan ZX, Zou J, Franklin R, et al. Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol. 2000;4:31–36
  9. Untergasser G, Rumpold H, Plas E, Witkowski M, Pfister G, Berger P. High levels of zinc ions induce loss of mitochondrial potential and degradation of antiapoptotic Bcl-2 protein in in vitro cultivated human prostate epithelial cells. Biochem Biophys Res Commun. 2000;279:607–614
  10. Feng P, Li TL, Guan ZX, Franklin RB, Costello LC. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate. 2002;52:311–318
  11. Vallee BL. The function of metallothionein. Neurochem Int. 1995;27:23–33
  12. Davis SR, Cousins RJ. Metallothionein expression in animals: a physiological perspective on function. J Nutr. 2000;130:1085–1088
  13. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol. 2000;59:95–104
  14. Theocharis S, Karkantaris C, Philipides T, Agapitos E, Gika A, Margeli A, et al. Expression of metallothionein in lung carcinoma: correlation with histological type and. Histopathology. 2002;40:143–151
  15. Cherian MG, Jayasurya A, Bay BH. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003;533:201–209
  16. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr. 2004;24:151–172
  17. Colvin RA, Fontaine CP, Laskowski M, Thomas D. Zn2+ transporters and Zn2+ homeostasis in neurons. Eur J Pharmacol. 2003;479:171–185
  18. Hasumi M, Suzuki K, Matsui H, Koike H, Ito K, Yamanaka H. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett. 2003;200:187–195
  19. Garrett SH, Sens MA, Shukla D, Flores L, Somji S, Todd JH, et al. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer. Prostate. 2000;43:125–135
  20. Sens MA, Somji S, Garrett SH, Beall CL, Sens DA. Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. Am J Pathol. 2001;159:21–26
  21. Jacob ST, Majumder S, Ghoshal K. Suppression of metallothionein-I/II expression and its probable molecular mechanisms. Environ Health Perspect. 2002;110(Suppl 5):827–830
  22. Costello LC, Liu Y, Zou J, Franklin RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem. 1999;274:17499–17504
  23. Rozsa FW, Reed DM, Scott KM, Pawar H, Moroi SE, Kijek TG, et al. Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis. 2006;12:125–141
  24. Palmiter RD, Findley SD, Whitmore TE, Durnam DM. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci U S A. 1992;89:6333–6337
  25. Schmidt CJ, Jubier MF, Hamer DH. Structure and expression of two human metallothionein-I isoform genes and a related pseudogene. J Biol Chem. 1985;260:7731–7737
  26. Stennard FA, Holloway AF, Hamilton J, West AK. Characterisation of six additional human metallothionein genes. Biochim Biophys Acta. 1994;1218:357–365
  27. Cousins RJ, Liuzzi JP, Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem. 2006;
  28. Missiaglia E, Blaveri E, Terris B, Wang YH, Costello E, Neoptolemos JP, et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer. 2004;112:100–112
  29. Li Z, Stonehuerner J, Devlin RB, Huang YC. Discrimination of vanadium from zinc using gene profiling in human bronchial epithelial cells. Environ Health Perspect. 2005;113:1747–1754
  30. Magda D, Lecane P, Miller RA, Lepp C, Miles D, Mesfin M, et al. Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines. Cancer Res. 2005;65:3837–3845
  31. Jasani B, Schmid KW. Significance of metallothionein overexpression in human. Histopathology. 1997;31:211–214
  32. Jin R, Chow VT, Tan PH, Dheen ST, Duan W, Bay BH. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis. 2002;23:81–86
  33. Tai SK, Tan OJ, Chow VT, Jin R, Jones JL, Tan PH, et al. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. Am J Pathol. 2003;163:2009–2019
  34. Wei H, Hong Y, Lin S, Clark A, Feng P. Regulation of metallothionein expression by zinc involved in oncogenesis of human prostate cells. Proc Amer Assoc Cancer Res. 2006;47:[Ref Type: Abstract]
  35. Yamada H, Koizumi S. DNA Microarray analysis of human gene expression induced by a non-lethal dose of cadmium. Industrial Health. 2002;40:159–166
  36. Uenishi R, Gong PF, Suzuki K, Koizumi S. Cross talk of heat shock and heavy metal regulatory pathways. Biochem Biophys Res Commun. 2006;341:1072–1077
  37. Murata M, Gong P, Suzuki K, Koizumi S. Differential metal response and regulation of human heavy metal-inducible genes. J Cell Physiol. 1999;180:105–113
  38. Seo JS, Park YM, Kim JI, Shim EH, Kim CW, Jang JJ, et al. T cell lymphoma in transgenic mice expressing the human Hsp70 gene. Biochem Biophys Res Commun. 1996;218:582–587
  39. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2000;2:469–475
  40. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci. 2004;117:5965–5973
  41. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 2005;41:2449–2461
  42. Yu RA, Yang CF, Chen XM. DNA damage, apoptosis and C-myc, C-fos, and C-jun overexpression induced by selenium in rat hepatocytes. Biomed Environ Sci. 2006;19:197–204

☆ Authors' contributions: Shu-fei Lin performed the microarray study, RT-PCR, data analysis, related statistical analyses and participated in manuscript preparation. Hua Wei performed RT-PCR, contributed and participated in producing the tables and figures. Dennis Maeder predicted the protein structure for MT-1J. Renty B. Franklin participated in the discussions and manuscript preparation. Pei Feng conceived the study, responded to its design, coordination, data analysis and the completion of the manuscript. All authors read and approved the final manuscript.

☆☆ This study was supported by funding from NIH/National Cancer Institute grant R01-116815 to P. Feng.

PII: S0955-2863(08)00213-1

doi: 10.1016/j.jnutbio.2008.09.004

The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 1000-1012 , December 2009

Article Tools

* Image Usage & Resolution